Blog

■ Rehospitalization following pediatric heart transplantation: incidence, indications, and risk factors

Nicole Lambert, Jeffrey G. Weiner, Matt Hall et al

Pediatr Cardiol. 2020 Mar; 41(3): 584–590

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176534/

 

■ Association of transplant center survival benefit among adults undergoing heart transplant in the United States

William F. Parker, Allen S. Anderson, Robert D. Gibbons et al

JAMA. 2019 Nov 12; 322(18): 1789–1798

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865773/

 

■ Current state of pediatric cardiac transplantation

Anne I. Dipchand

Ann Cardiothorac Surg. 2018 Jan; 7(1): 31–55

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827130/

 

■ The past, present and future of heart transplantation

In-Cheol Kim, Jong-Chan Youn, Jon A. Kobashigawa

Korean Circ J. 2018 Jul; 48(7): 565–590

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031715/

 

■ Endocrine disorders after heart transplantation: national cohort study

Matej Rakusa, Bojan Vrtovec, Gregor Poglajen et al

BMC Endocr Disord. 2020; 20: 54

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171847/

 

■ Use of idarucizumab to revert the anticoagulant effect of dabigatran in heart transplant surgery: an institutional experience

Álvaro Herrera-Escandón, Orlando Castaño-Cifuentes, Carlos A. Plata-Mosquera

Case Rep Cardiol. 2020; 2020: 6927423

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081017/

 

■ Transplante cardíaco: revisão

S Mangini et al

Einstein (São Paulo) 2015, vol 13 (2): 310-318

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200025&lng=pt&nrm=iso&tlng=pt (portuguese)

 

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200025&lng=pt&nrm=iso&tlng=en (english)

 

■ Infections in heart, lung, and heart-lung transplantation

Andrés F. Henao-Martínez, José G. Montoya

Principles and Practice of Transplant Infectious Diseases. 2018 Dec 8 : 21–39

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121494/

 

■ Pediatric heart transplantation – indications and outcomes in the current era

Philip T. Thrush, Timothy M. Hoffman

J Thorac Dis. 2014 Aug; 6(8): 1080–1096

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133537/

 

■ Heart transplantation for advanced heart failure

Daniel E. Westerdahl, Jon A. Kobashigawa

Cardiac Intensive Care. 2019 : 504–524.e2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161392/

 

■ Efficacy and safety of empagliflozin in the management of diabetes mellitus in heart transplant recipients

Matthew G. Cehic, Christopher A. Muir, Jerry R. Greenfield, et al

Transplant Direct. 2019 May; 5(5): e450

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511439/

 

■ Exercise-based cardiac rehabilitation in heart transplant recipients

Lindsey Anderson, Tricia T Nguyen, Christian H Dall, et al

Cochrane Heart Group

Cochrane Database Syst Rev. 2017 Apr; 2017(4): CD012264.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478176/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: julho 2020

 

■ Phosphodiesterase type 5 inhibitors and COVID-19: Are they useful in disease management?

Nicola Mondaini

World J Mens Health. 2020 Jul; 38(3): 254–255

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308240/

 

■ Is non-chlamydial non-gonococcal urethritis associated with significant clinical complication in men? A systematic review

Cassandra E.L. Fairhead, Alexander Hampson, Louis Dwyer-Hemmings, Nikhil Vasdev

Curr Urol. 2020 Mar; 14(1): 1–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206600/

 

■ Should all men with type 2 diabetes be routinely prescribed a phosphodiesterase type 5 inhibitor?

Geoffrey Hackett

World J Mens Health. 2020 Jul; 38(3): 271–284

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308237/

 

■ Metabolic syndrome and the composition of urinary calculi: is there any relation?

Pedro Valente, Hélder Castro, Inês Pereira et al

Cent European J Urol. 2019; 72(3): 276–279

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830491/

 

■ Testosterone and dehydroepiandrosterone treatment in ageing men: Are we all set?

Andreas Walther, Julian Seuffert

World J Mens Health. 2020 Apr; 38(2): 178–190

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076306/

 

■ Does urethral length affect continence outcomes follwing robot assisted laparoscopic radical prostatectomy (RALP)?

Diwei Lin, Michael O’Callaghan, Rowan David, et al

BMC Urol. 2020; 20: 8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995073/

 

■ Post-radical prostactomy urinary incontinence: is there any discrepancy between medical reports and patients perceptions?

Rafael Castilho Borges, Marcos Tobias-Machado, Estefânia Nicoleti Gabriotti, et al

BMC Urol. 2019; 19: 32

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501406/

 

■ Is there a role for levo-thyroxine for the treatment of arterial erectile dysfunction? The clinical relevance of the mean platelet volume

Rossella Cannarella, Aldo E. Calogero, Antonio Aversa et al

J Clin Med. 2020 Mar; 9(3): 742

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141360/

 

■ Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Kerri Beckmann, Netty Kinsella, Henrik Olsson et al

BMC Urol. 2019; 19: 73

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683376/

 

■ Prostate cancer screening among elderly men in Brazil: should we diagnose or not?

Mori, Rafael Ribeiro et al.

Int. braz j urol., Feb 2020, vol.46, no.1, p.34-4

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382020000100034&lng=en&nrm=iso

 

■ Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?

Karolina Semczuk-Kaczmarek, Anna E. Płatek, Filip M. Szymański

Cent European J Urol. 2020; 73(1): 42–4

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203768/

 

■ Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms

Nassim Aourag, Johan F. Langenhuijsen, Frank d’Ancona, John Heesakkers

Cent European J Urol. 2019; 72(1): 39–4

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469014/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: julho 2020